Mayo Clinic proceedings
-
Mayo Clinic proceedings · Aug 2022
Randomized Controlled TrialTricuspid Regurgitation Impact on Outcomes (TRIO): A Simple Clinical Risk Score.
To determine which clinical variables infer the highest risk for mortality in patients with notable tricuspid regurgitation (TR) and to develop a clinical assessment tool (the Tricuspid Regurgitation Impact on Outcomes [TRIO] score). ⋯ The TRIO score is a simple clinical tool for risk assessment in patients with notable TR. Future prospective studies to validate its use are warranted.